Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-04-25FDA Approved: CLOZAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approves a supplemental application for Clozapine from Aurobindo Pharma Limited, indicating approval of a supplemental submission for a …
-
FDA approval · 2017-04-25FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Clozapine submitted by Mylan Pharmaceuticals Inc., granting updated marketing authorization for …
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating a community-based management model using long-acting injectable antipsychotics to reduce violence risk in …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging [NA]
A completed Vanderbilt-sponsored clinical trial update describes using fMRI to quantify abnormal cortical activation associated with auditor…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Optimisation of Antipsychotic Drug Use in Older People [Phase 4]
Phase 4 clinical trial update on optimizing antipsychotic use in older people with Alzheimer's disease or schizophrenia; the study has been …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium [Phase 1]
A Phase 1 pilot trial compared xanomeline alone to xanomeline plus trospium in people with schizophrenia and has completed. The study was sp…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Oxytocin Treatment of Schizophrenia [NA]
A completed clinical trial evaluating oxytocin as a treatment for schizophrenia, with results posted in 2017.
-
CLINICAL_TRIALS research · 2017-04-13Clinical Trial Update: Vitamin D for Schizophrenia [NA]
A completed clinical trial evaluating vitamin D for schizophrenia, including clozapine-resistant cases.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism [Phase 2]
Phase 2 trial assessing a treatment to facilitate NMDA receptor function in patients with schizophrenia and co-morbid alcoholism; study comp…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone [Phase 3]
Phase 3 trial evaluating cognitive remediation in schizophrenia or schizoaffective disorder patients stabilized on lurasidone has completed …
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid Supplementation [Phase 2]
Phase 2 trial evaluating whether omega-3 fatty acid supplementation lowers coronary artery disease risk in people with schizophrenia or schi…
-
CLINICAL_TRIALS research · 2017-04-04Clinical Trial Update: Patient Guided Psychiatric Admissions [NA]
This is a completed clinical trial update about patient-guided psychiatric admissions. The conditions studied include schizophrenia and bipo…
-
FDA approval · 2017-03-29FDA Approved: ARIPIPRAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved Alembic Pharmaceuticals' supplemental application for aripiprazole, enabling the marketing of a generic aripiprazole product.
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry [Phase 2]
A Phase 2 trial sponsored by Janssen evaluated the clinical utility of measuring antipsychotic medication levels in plasma using LC-MS/MS. T…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Treatment Effects From Aerobic Endurance Training and Maximal Strength Training in Patients Suffering From Schizophrenia [NA]
A completed clinical trial evaluated the effects of aerobic endurance training and maximal strength training in patients with schizophrenia,…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Study of the Effects of Mecamylamine and Varenicline in Schizophrenia [NA]
A completed clinical trial evaluating the effects of mecamylamine and varenicline on cognition in schizophrenia; results were posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-03-27Clinical Trial Update: Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia [Phase 3]
Phase 3 safety and tolerability study of oral OPC-34712 as maintenance treatment in adults with schizophrenia has completed and results were…
-
CLINICAL_TRIALS trial_result · 2017-03-24Clinical Trial Update: Add-on Simvastatin in Schizophrenia Trial [NA]
This update reports on a trial testing add-on simvastatin for schizophrenia, sponsored by the New York State Psychiatric Institute. The tria…
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: SB-773812 Administered In Adults With Schizophrenia [Phase 2]
Phase 2 trial of SB-773812 in adults with schizophrenia has completed (status: COMPLETED). GlaxoSmithKline is the sponsor.
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Improving Care and Reducing Cost Study [NA]
A completed clinical trial update from Northwell Health. The study aims to improve care and reduce costs for schizophrenia, schizoaffective …
-
CLINICAL_TRIALS trial_result · 2017-03-23Clinical Trial Update: Antipsychotics and Gene Expression in Soft Tissues [Phase 4]
Phase 4 clinical trial update from Medical University of Vienna investigating antipsychotics and gene expression in soft tissues in schizoph…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Pediatric Schizophrenia Efficacy and Safety Study [Phase 3]
Phase 3 pediatric schizophrenia efficacy and safety trial completed; results were posted in 2017.
-
CLINICAL_TRIALS research · 2017-03-20Clinical Trial Update: Computerised Interventions for Thinking and Anxiety in Delusions (CITADEL) Trial [NA]
This update notes the completion of the CITADEL trial, which investigates computerised interventions aimed at thinking patterns and anxiety …
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia [Phase 2]
This clinical trial update notes the completion of a Phase 2 study evaluating NW-3509A for safety, tolerability, and efficacy in schizophren…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals [NA]
This clinical trial update presents 3-year follow-up clinical outcomes after discontinuation of antipsychotic treatment in individuals with …